Visual Trails: Do the Doors of Perception Open
                    Periodically? by Dubois, Julien & VanRullen, Rufin
Unsolved Mystery
Visual Trails: Do the Doors of Perception Open
Periodically?
Julien Dubois
1,2*, Rufin VanRullen
1,2
1Universite ´ de Toulouse, Centre de Recherche Cerveau et Cognition, Universite ´ Paul Sabatier, Toulouse, France, 2Centre National de la Recherche Scientifique, UMR5549,
Faculte ´ de Me ´decine de Purpan, Toulouse, France
‘‘Visual trailing’’ is a transient but dramatic disturbance of
visual motion perception of unknown origin: the subject perceives
a series of discrete stationary images trailing in the wake of
otherwise normally moving objects. Although this phenomenon is
most frequently encountered after ingestion of prescription and/or
illicit drugs (most commonly with lysergic acid diethylamid, or
LSD), it has also occasionally been reported following brain
damage or neurological disorders. A quantitative account of visual
trails is lacking; we argue that careful experimental investigation
could potentially reveal how our brains update conscious visual
perception in time.
What Do Visual Trails Look Like?
Ask any LSD user: they know the drug is taking effect when the
‘‘good trails’’ kick in. Trailing is a visual perceptual effect commonly
experienced during LSD consumption and as a long-lasting side
effect of the drug (hallucinogen persisting perception disorder) [1–
4]. LSD users perceive a series of discrete positive afterimages in the
wake of moving objects, a percept that has been likened to a
multiple-exposure stroboscopic photograph, somewhat akin to
Etienne-Jules Marey’s chronophotographs [5] from 1880, or to
more recent digital art produced in a few clicks (Figure 1).
Trailing is a visual disturbance that has been observed under
various conditions. While some authors use the terminology of LSD
users [1–3,6,7], others describe the phenomenon in more clinically
suited terms: examples are ‘‘akinetopsia’’ [8,9], ‘‘polyopia’’[9],
‘‘palinopsia’’ [4,10–13], or ‘‘visual perseveration’’ [14]. In Table 1,
we clarify the meaning of each of these terms (according to [5,8,15–
21]). However, none of these terms precisely captures the specific
elements of visual trails: they occur only for moving objects (unlike
polyopia); moving objects are still perceived as moving (unlike
akinetopsia); duplicate images are perceived only in the presence of
real objects (unlike palinopsia); and, most importantly, visual trails
are not mere streaks ([22]), as would appear on a long-exposure
photographofmovingobjects(visualperseveration).Rather,trailing
consists of a discrete series of snapshots of the moving object along
its past trajectory, as if successive frames of a movie had been
superimposed. These phenomenological features of trailing are
clearly portrayed in the case reports that we collected (Box 1). The
discreteness of the trailing percept, in particular, is one of its most
characteristic, and most mysterious, aspects.
Who Experiences Visual Trails?
While LSD induces trailing [1–3,23], consumption of other
hallucinogens like psilocin and mescaline has not been linked with
such visual disturbances in the clinical literature (to our
knowledge). Either their interaction with the receptors that
mediate trailing is not as potent, or LSD acts at sites that other
hallucinogens do not bind with (for a review of the pharmacology
of hallucinogens, see [24] and for LSD more specifically, see
[25,26]). Reports pertaining to the past use of illicit drugs are,
however, poorly controlled (a good example is a report of illegal
marijuana leading to trailing by Levi and Miller [27], in which
they explicitly acknowledge that their cases may be confounded by
the presence of impurities in illegal marijuana, as well as by past
use of LSD).
A better understanding of the pharmacology of trailing may arise
from the report of similar visual disturbances following the use of
prescription drugs. The chemistry and dosage of prescription drugs
is well controlled, which is not the case for illicit drugs. Nefazodone,
for instance, is a recent antidepressant drug with multiple reports of
episodes of visual trails as a side effect [6–8,28]. A closely related
antidepressant drug, trazodone, can induce similar side effects [10];
so can mirtazapine [29], and, possibly, risperidone (the study is
inconclusive due to the concurrent administration of trazodone
[30]). These four antidepressant drugs all antagonize 5-HT2a and
5-HT2c receptors, and it has been proposed that this is at the origin
of the trailing phenomenon [28]. However, the first recognized
inducer of visual trails, LSD, has the opposite effect (agonist activity)
at both these receptors [24–26]. Common to these antidepressant
drugs and LSD is an increase in extracellular serotonin levels
(indeed, all these drugs have been linked to serotonin syndrome
[31], a form of poisoning due to excess serotoninergic activity that
causes a range of symptoms, including hallucinations, elevated body
temperature, and fast heart beat). Although the evidence is
suggestive of a link between serotonin and visual trailing, the
widespread action of serotonin throughout the brain prevents us
from speculating further for the time being.
Visual trails have also been experienced with other drugs with
very different pharmacology. The antiepileptic drug topiramate,
which, among other actions, blocks voltage-dependent sodium
channels and increases GABA activity at some GABA-A receptor
subtypes, has been involved with visual trails [11,12]. Increased
inhibition, mediated by higher levels of serotonin or GABA
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the ones described previously. Topiramate also inhibits cyto-
chrome isoform CYP2D6 [32], which has been associated with
serotonin syndrome [31].
Besides pharmacologically induced trailing, some clinical reports
from neuropsychological populations deserve to be mentioned. A
crisp account of migraine patients experiencing trailing is given by
Sacks [5], where he estimates the frequency of snapshots at ‘‘six to
twelve frames per second’’ (see also [33]). We found one other
report of visual trails (combined with akinetopsia and palinopsia) in
migraineurs [34] (see also medical doctor Klaus Podoll’s Web site
[35]). On the whole, trailing is a very rare disturbance for migraine
sufferers, the migraine being a very heterogeneous condition that
affects roughly 20% of the population at one time or another; the
possibility exists that the disturbance occurs only for a very specific
and rare form of migraine, or is a side effect of drugs that patients
take to relieve their symptoms [12]. As a side note of interest,
controlled studies have found migraine patients to have impair-
ments for global motion perception [36] (see also [37]).
A recent case study [9] described visual trails associated with
another neurological condition: the posterior cortical atrophy
variant of Alzheimer’s disease [38]. The symptoms are referred to
as akinetopsia/polyopia by the authors, but their description
corresponds to a direction-specific version of trailing (visual trails
are perceived when objects move from right to left, but not when
they move from left to right). Direction-specificity restricts the
mechanistic models that can be put forward to explain visual trails;
however, the etiology is very different from previously discussed
cases, and in the absence of other reports of directional trailing, it
is premature to draw conclusions from this report.
Finally, a very rare disturbance of motion perception, for which
Zeki coined the word akinetopsia [15], can follow bilateral lesions
in the occipito-temporo-parietal cortices [39]. Patient L. M.
permanently lost motion perception (except for slowly moving
objects [40]). Instead of seeing a moving object, she saw the object
in a series of stills, as in a movie run too slowly. This is a rather
extreme case that differs qualitatively from trailing (see Table 1),
but it may ultimately rely on similar mechanisms.
What May Cause the Perception of Visual Trails?
Visual trails, because of their discrete and repetitive nature, may
represent the perceptual manifestation of an underlying periodic
process. This periodicity could arise outside of the neural system (e.g.,
eye movements, motor tremor), or may be the result of faulty motion
computation mechanisms (e.g., motion smear suppression), or, finally,
may point to a more general, quasi-periodic sampling process that
affects, among other things, the motion perception system. These three
(non-exhaustive and non-exclusive) possibilities are developed below.
Do Visual Trails Arise from Abnormal Eye Movements?
Trailing may not originate in the neural pathways at all. For
example, if visual trails are only perceived when subjects track a
moving object with their eyes, the discrete afterimages may be caused
by a defective, jerky smooth-pursuit mechanism. Saccadic suppres-
sion would operate while the eyes execute repeated corrective
saccades to keep track of the moving object, shutting on and off the
Figure 1. Multiple-exposure stroboscopic photograph. This illustrates (inasmuch as possible with a static image) the perception experienced
during trailing.
doi:10.1371/journal.pbio.1001056.g001
Box 1. Selected Case Reports
Lysergic acid diethylamide (LSD) ‘‘[When asked] if they
ever ‘saw any trails’, [the subject] would wave a hand across
the visual field and say ‘Oh, you mean these?’ The subject
could then describe a trail of images of the moving hand,
muchliketheframesofapieceofmotionpicture filmfrozen
in space long enough for the subject to see them’’ [3].
Nefazodone ‘‘A 47-year-old man reported seeing streams
of multiple, frozen images trailing in the wake of moving
objects. As soon as motion ceased, the images collapsed
into each other. He compared his vision to a scene lit by a
flashing strobe, except that stationary elements were
perceived normally. In fact, if nothing was in motion and
he held perfectly still, his vision was entirely normal. The
moment anything moved, however, it left a stream of static
copies in its path. For example, while out for an evening
stroll, he saw a pack of identical dogs lined up behind his
West Highland terrier. Driving was impossible because he
was confused by multiple snapshots of cars, streets, and
signs. Moving lights were followed by a long comet tail’’ [8].
Trazodone ‘‘He began to have numerous morning
episodes of ‘strobe images’. They were most apt to occur
in dim illumination. He described looking at the door of his
bedroom and seeing multiple images of the door ‘march’
across his field of vision when he shifted his gaze to the
bureau on the other side of the room. The false images
were intense, and he had many such episodes every
morning, each lasting 15 minutes or less’’ [10].
Mirtazapine ‘‘As she watched her husband walk past her,
she saw multiple afterimages of him as if he were leaving a
visual trail. These afterimages were less color intensive
than the normal visual image, slightly blurred, and faded
away after 30 seconds to 1 minute. The phenomenon
repeated itself with most moving objects and was
generally more pronounced with objects in Ms. A’s
lateral visual fields’’ [29].
Topiramate ‘‘Ms. A reported seeing ‘picture in picture’
images, like she was in a ‘discotheque’, or in a place with
stroboscopic lights. Those persistent ‘frozen pictures’
faded away after a few seconds. The phenomenon
repeated itself with most moving objects’’ [11].
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trailing often recount that trails follow just one or a few moving
objects at a time, rather than affecting the entire visual scene, as
would be the case after eye movements (or uncontrolled tremors).
This makes such a motor explanation unlikely; nonetheless, a well-
controlled eye tracking experiment on individuals experiencing visual
trails would be essential to evaluate this hypothesis.
Do Visual Trails Reflect a Failure of Specific Motion
Perception Mechanisms?
The periodicity may arise as a disturbance of certain motion
processes that are normally continuous. For example, motion
streak suppression [41] is an inhibitory mechanism allowing the
brain to regulate the smear that a moving object leaves in its wake,
owing to visible persistence (an image normally takes about
100 ms to fade from perception, long enough to blur the trajectory
of a moving object as in a long-exposure photograph). Under the
effects of LSD or related drugs, the streak suppression process
might fall out of its normal operating range, resulting in stronger
than normal local inhibition followed by excitatory rebound. This
hypothesis would predict that trailing is accompanied by abnormal
oscillatory activity confined within the motion perception system, a
prediction that could be verified in human or non-human primates
with appropriate recordings.
Could Visual Trails Be the Manifestation of Periodicities
Inherent to all Perceptual Processes?
Trailing may reflect a more widespread rhythmic activity
affecting (possibly among other modules) the motion perception
system.Twoalternatives mustbe distinguished here, whichcould be
teased apart by comparing oscillatory brain activity in the normal
and drug-altered states. Either this rhythmic activity is directly
produced by the drug (or at least, increased beyond perceptual
threshold)—a rise of inhibition could generate prominent oscilla-
tions, turning the normally continuous processing of visual
information into a series of discrete snapshots—or this periodicity
is always present in the normal brain, but inaccessible to conscious
perception. In the latter case, the drug may increase visible
persistence, or disrupt motion streak suppression, two processes that
would normally serve to hide the discrete visual trails.
Related Phenomena Pointing to Periodicities in
Visual Perception
A persistent thread in the perceptual literature is that temporal
binning is, indeed, common to all of perception (reviewed by [42]).
One of the most striking phenomenological manifestations of the
discrete nature of perception is the so-called ‘‘continuous wagon
wheel illusion’’: in plain sunlight, a continuously rotating, spoked
wheel can be perceived to rotate in a direction opposite to its true
motion. While movie watchers are accustomed to this percept
(which follows from an undersampling of the continuous motion of
the wheel by the discrete frame rate of the camera and the movie
projection system), perceiving reversals in conditions of continuous
illumination is more challenging. Quasi-periodic sampling or
binning processes within the visual system have been proposed as
an explanation; this interpretation has been a subject of
controversy, and many experiments have been conducted to test
it. In light of these recent experiments, VanRullen and colleagues
hypothesized that attentional processes may function in a quasi-
periodic manner [43,44]: when attention is deployed, it samples
information at discrete moments in time. The rate of sampling
may be dependent on the task at hand [43,45,46]. One
component of this theory purports that the attentive motion
system takes discrete samples of the object in motion to compute
its trajectory. Past snapshots are usually concealed from conscious
perception—but some substances may interfere with their proper
suppression, giving rise to the trailing phenomenon.
Towards a Solution: Measuring Visual Trails
How many ‘‘ghost images’’ [23] trail in the wake of the moving
objects? How far apart are the ‘‘discrete and discontinuous
images’’ [2]? How long do they persist for? These questions have,
so far, not been answered. In fact, visual trails have been
considered an annoyance at best, and quantifying them has not
been the main concern in the various clinical settings in which they
were observed. Careful quantitative investigation will be needed to
shed light on the mechanisms that cause visual trails to appear as a
discrete series of snapshots of the moving object.
As a preliminary step towards quantitative answers, we
conducted an online survey in which we asked self-declared past
LSD users to decide which of ten short movies with simulated
visual trails best matched their recollected experience. We varied
the interval between simultaneously perceived snapshots from
25 ms to 250 ms, keeping the number of concurrently visible
repetitions to four. For over more than 210 participants, the
responses were not randomly distributed across the ten choices,
but followed a highly consistent pattern (chi-squared test,
p,0.0008) with a preference for faster snapshot periodicities;
participants selected a time interval between images of 67 ms on
average, corresponding to an underlying periodicity in the 15–
20 Hz (beta) range. Although this is the first study that tries to
quantitatively assess the frame rate of LSD-induced visual trails, it
Table 1. Glossary.
TRAILING An object in motion is followed by a discrete series of stationary images that slowly fade out along its trajectory
Our Definition How It Differs from Trailing
AKINETOPSIA An object in motion is not perceived as moving continuously; rather,
it is experienced as a series of stills
The perception of motion is abolished and a single frame
can be seen at any one time
POLYOPIA Multiple images of an object (from two to 100 in extreme cases) are
perceived simultaneously
Polyopia is not specific to objects in motion
VISUAL PERSEVERATION A positive afterimage persists after removal of an object Visual perseveration for a moving object would leave a
blur in its wake, rather than discrete images
PALINOPSIA Similar to visual perseveration; some authors describe a lag between the
removal of the object and the onset of the afterimage
Same as visual perseveration, potentially with a gap
between the moving object and the perseverant tail
doi:10.1371/journal.pbio.1001056.t001
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individuals who take the survey, as they do so anonymously from
their home computer. However, this protocol follows a new trend
in psychological research of using the Web for large-scale studies
(see the http://www.testmybrain.org/ Web site recently created
by Harvard scientists). Second, the responses rely on the memory
of the percept, which may be faulty. Last, the chemical
composition and dose taken by each individual is not controlled,
which is problematic considering that more than 200 types of LSD
tablets have been encountered since 1969 and more than 350
blotter paper designs have been in circulation since 1975 [47]
(also, some blotters sold as LSD are in fact mimics). In fact, some
of the most experienced users indicated that trailing is dose
dependent. For all these reasons, one must be cautious in
interpreting these initial results. The movie used for the survey
as well as a results summary can be found online at http://www.
cerco.ups-tlse.fr/,rufin/lsdsurvey.
Collecting further quantitative data with individuals who
experience visual trailing will be necessary to tease apart the
alternative accounts—possibly in combination with computational
modeling. Solving the mystery of the origins of the trailing effect
might reveal something deep about the mechanisms underlying
perception, challenging the way we think we perceive the world.
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